Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation

Circulation: Arrhythmia and Electrophysiology

Volumn 7, Issue 3, 2014, Pages 483-489

  Dinov, Borislav ^a   Kosiuk, Jedrzej ^a   Kircher, Simon ^a   Bollmann, Andreas ^a   Acou, Willem Jan ^a   Arya, Arash ^a   Hindricks, Gerhard ^a   Rolf, Sascha ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Atrial fbrillation

Indexed keywords

ATRIAL FIBRILLATION;

AGED; ATRIAL FIBRILLATION; ATRIAL REMODELING; BLOOD CHEMICAL ANALYSIS; BODY SURFACE POTENTIAL MAPPING; CATHETER ABLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TACHYCARDIA, PAROXYSMAL; TREATMENT OUTCOME;

EID: 84905824307     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.001185     Document Type: Article

References (32)

1. Crabos M, Roth M, Hahn AW, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fbroblasts. Coupling to signaling systems and gene expression. J Clin Invest. 1994;93:2372-2378.
2. Oudot A, Vergely C, Ecarnot-Laubriet A, Rochette L. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reper- fusion. Eur J Pharmacol. 2003;462:145-154.
3. Wu S, Gao J, Ohlemeyer C, Roos D, Niessen H, Köttgen E, Gessner R. Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes. Free Radic Biol Med. 2005;39:1601-1610.
4. Choi EK, Chang PC, Lee YS, Lin SF, Zhu W, Maruyama M, Fishbein MC, Chen Z, Rubart-von der Lohe M, Field LJ, Chen PS. Triggered fring and atrial fbrillation in transgenic mice with selective atrial fbrosis induced by overexpression of TGF-β1. Circ J. 2012;76:1354-1362.
5. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51:1938-1948.
6. Pike GK, Bretag AH, Roberts ML. Modifcation of the transient outward current of rat atrial myocytes by metabolic inhibition and oxidant stress. J Physiol. 1993;470:365-382.
7. Fukuda K, Davies SS, Nakajima T, Ong BH, Kupershmidt S, Fessel J, Amarnath V, Anderson ME, Boyden PA, Viswanathan PC, Roberts LJ 2nd, Balser JR. Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res. 2005;97:1262-1269.
8. Shang LL, Sanyal S, Pfahnl AE, Jiao Z, Allen J, Liu H, Dudley SC Jr. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol. 2008;294:C372-C379.
9. Caballero R, Gómez R, Moreno I, Nuñez L, González T, Arias C, Guizy M, Valenzuela C, Tamargo J, Delpón E. Interaction of angiotensin II with the angiotensin type 2 receptor inhibits the cardiac transient outward potassium current. Cardiovasc Res. 2004;62:86-95.
10. Kasi VS, Xiao HD, Shang LL, Iravanian S, Langberg J, Witham EA, Jiao Z, Gallego CJ, Bernstein KE, Dudley SC Jr. Cardiac-restricted angiotensin- converting enzyme overexpression causes conduction defects and connex-in dysregulation. Am J Physiol Heart Circ Physiol. 2007;293:H182-H192.
11. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovasc Res. 2001;51:217-229.
12. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L, Bai D. Somatic mutations in the connexin 40 gene (GJA5) in atrial fbrillation. N Engl J Med. 2006;354:2677-2688.
13. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fbrillation in human patients. Cardiovasc Res. 2002;54:361-379.
14. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N. Atrial fbrosis helps select the appropriate patient and strategy in catheter ablation of atrial fbrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol. 2011;22:16-22.
15. Platonov PG, Mitrofanova LB, Orshanskaya V, Ho SY. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fbrillation but not with age. J Am Coll Cardiol. 2011;58:2225-2232.
16. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ. Obesity and the risk of new-onset atrial fbrillation. JAMA. 2004;292:2471-2477.
17. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y. Metabolic syndrome and risk of development of atri-al fbrillation: the Niigata preventive medicine study. Circulation. 2008;117:1255-1260.
18. Rosiak M, Dziuba M, Chudzik M, Cygankiewicz I, Bartczak K, Drozdz J, Wranicz JK. Risk factors for atrial fbrillation: not always severe heart disease, not always so 'lonely'. Cardiol J. 2010;17:437-442.
19. Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P. Association of the metabolic syndrome with atrial fbrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol. 2011;108:227-232.
20. Umetani K, Kodama Y, Nakamura T, Mende A, Kitta Y, Kawabata K, Obata JE, Takano H, Kugiyama K. High prevalence of paroxysmal atrial fbrillation and/or atrial futter in metabolic syndrome. Circ J. 2007;71:252-255.
21. Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Zagrodzky J, Natale A. Impact of metabolic syndrome on procedural outcomes in patients with atrial fbrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59:1295-1301.
22. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, Ma CS. Metabolic syndrome and risk of recurrence of atrial fbrillation after catheter ablation. Circ J. 2009;73:438-443.
23. Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, Tsao HM, Chang CJ, Tsai WC, Chen SA. Comparison of outcome in catheter ablation of atrial fbrillation in patients with versus without the metabolic syndrome. Am J Cardiol. 2009;103:67-72.
24. Berkowitsch A, Kuniss M, Greiss H, Wójcik M, Zaltsberg S, Lehinant S, Erkapic D, Pajitnev D, Pitschner HF, Hamm CW, Neumann T. Impact of impaired renal function and metabolic syndrome on the recurrence of atri-al fbrillation after catheter ablation: a long term follow-up. Pacing Clin Electrophysiol. 2012;35:532-543.
25. Chao TF, Suenari K, Chang SL, Lin YJ, Lo LW, Hu YF, Tuan TC, Tai CT, Tsao HM, Li CH, Ueng KC, Wu TJ, Chen SA. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fbril-lation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010;106:1615-1620.
26. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF. Detection and quan-tifcation of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fbrillation. Circulation. 2009;119:1758-1767.
27. Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, Edwards D, Marine JE, Calkins H, Nazarian S. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9: 2003-2009.
28. de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation. 1993;88:915-926.
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
30. Sanders P, Morton JB, Kistler PM, Spence SJ, Davidson NC, Hussin A, Vohra JK, Sparks PB, Kalman JM. Electrophysiological and electroana-tomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation. 2004;109:1514-1522.
31. Marcus GM, Yang Y, Varosy PD, Ordovas K, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. Regional left atrial voltage in patients with atrial fbrillation. Heart Rhythm. 2007;4:138-144.
32. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, Bhargava M, Belden WA, Abdul-Karim A, Natale A. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45:285-292.